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Abstract 
Background: The large-scale introduction of malaria rapid diagnostic tests (RDTs) promises to improve management 
of fever patients and the rational use of valuable anti-malarials. However, evidence on the impact of RDT introduction 
on the overprescription of anti-malarials has been mixed. This study explored determinants of provider  
decision- making to prescribe anti-malarials following a negative RDT result.
Methods: A qualitative study was conducted in a rural district in mid-western Uganda in 2011, ten months after RDT 
introduction. Prescriptions for all patients with negative RDT results were first audited from outpatient registers for 
a two month period at all facilities using RDTs (n = 30). Facilities were then ranked according to overall prescribing 
 performance, defined as the proportion of patients with a negative RDT result prescribed any anti-malarial. Positive 
and negative deviant facilities were sampled for qualitative investigation; positive deviants (n = 5) were defined ex 
post facto as <0.75 % and negative deviants (n = 7) as >5 %. All prescribing clinicians were targeted for qualitative 
observation and in-depth interview; 55 fever cases were observed and 22 providers interviewed. Thematic analysis 
followed the ‘framework’ approach.
Results: 8344 RDT-negative patients were recorded at the 30 facilities (prescription audit); 339 (4.06 %) were 
 prescribed an anti-malarial. Of the 55 observed patients, 38 tested negative; one of these was prescribed an 
 anti-malarial. Treatment decision-making was influenced by providers’ clinical beliefs, capacity constraints, and 
 perception of patient demands. Although providers generally trusted the accuracy of RDTs, anti-malarial prescription  
was driven by perceptions of treatment failure or undetectable malaria in patients who had already taken  
artemisinin-based combination therapy prior to facility arrival. Patient assessment and other diagnostic practices were 
minimal and providers demonstrated limited ability to identify alternative causes of fever. Provider perceptions of 
patient expectations sometimes appeared to influence treatment decisions.
Conclusions: The study found high provider adherence to RDT results, but that providers believed in certain  clinical 
exceptions and felt they lacked alternative options. Guidance on how the RDT works and testing following partial 
treatment, better methods for assisting providers in diagnostic decision-making, and a context-appropriate provider 
behaviour change intervention package are needed.
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Background
Malaria rapid diagnostic tests (RDT) allow countries to 
provide access to accurate malaria diagnosis in even the 
most remote areas, by means of a relatively simple to use, 
point-of-care test [1]. The World Health Organization 
(WHO) now advocates a universal ‘test, treat and track’ 
strategy, which recommends confirmatory parasite-based 
diagnosis in all patients suspected of having malaria 
before treating according to test results [2]. The aim is to 
improve quality of care, as well as to avoid overdiagnosis 
of cases which can lead to inappropriate or delayed treat-
ment, reduce wastage of anti-malarial drugs, and enable 
effective malaria surveillance, of critical importance in 
the context of declining malaria mortality [2, 3]. In recent 
years, many national malaria control programmes across 
Africa have adjusted treatment policies to restrict anti-
malarial prescription to patients with parasite-based 
diagnosis and have begun the process of scaling up diag-
nostic testing across the public health system [3].
The current Uganda Malaria Reduction Strategic Plan 
(2014–2020) recommends parasite-based diagnosis with 
microscopy or RDTs as part of malaria case management 
at all health facility levels for all age groups, and for tar-
geted groups (children under five) at the community level 
[4]. RDTs are to be used to extend the access frontier 
at Health Centre (HC) III’s without functional micros-
copy, HC II’s and at the community level. Since 2005, 
the Uganda malaria treatment policy has specified arte-
misinin-based combination therapy (ACT), specifically 
artemether-lumefantrine (AL) (Coartem®), as the first-
line treatment for uncomplicated malaria, with artesu-
nate-amodiaquine (AS/AQ) as an alternative [5]. While 
the existing diagnostic and treatment policies have been 
rolled out in public health facilities across the country, 
adherence to policy remains suboptimal with assessment 
of clinical symptoms continuing to drive some malaria 
diagnosis and mixed reports on treatment according to 
test results. Like many other malaria-endemic countries, 
Uganda regularly faces chronic ACT stockouts [6], and 
malaria overdiagnosis and the overprescription of ACT 
have long been widely acknowledged problems [7]. As 
malaria prevention activities are scaled up—Uganda 
completed a universal coverage distribution of long-last-
ing insecticide-treated nets (LLINs) in 2014—appropriate 
clinical decision-making around diagnosis and treatment 
becomes even more critical given the range of causes of 
fever and the importance of accurate case data for pro-
gress monitoring and surveillance.
For providers working in remote areas with limited 
means, the introduction of RDTs has denoted a major 
shift from the long-standing practice of treating all fevers 
presumptively as malaria. If the benefits of rapid diagnos-
tic testing are to be accrued, providers must believe in 
the validity of, and treat according to, test results. Para-
site-based testing can be empowering, allowing providers 
to confidently diagnose patients with malaria. However, 
in many contexts, the majority of patients presenting 
with fever will test negative [1, 8]. How these patients are 
managed—what diagnosis and treatment they receive (if 
not malaria)—is one of the key questions associated with 
RDT introduction. Yet, relatively little is known about 
how providers construct meaning from the test results 
in practice and how they integrate this information into 
clinical decision-making processes.
To date, evidence on the impact of introducing RDTs 
on the overprescription of anti-malarials has been mixed, 
with some significant success stories, but also a broad 
set of challenges emerging across a number of countries. 
Studies in clinical settings have reported a full range of 
adherence to negative test results, with anywhere from 
4 to 85  % of RDT-negative patients treated for malaria 
[9–19]. Other studies have indicated a steady adoption 
of ‘test and treat’ strategies as health provider reluctance 
and other disenabling factors are overcome [20, 21]. In 
Uganda, two studies have reported moderate adherence 
(25–35 %) to test results [22, 23], with some evidence that 
compliance may improve over time with increased use 
and experience [22].
In part, the wide range of results with regards to test 
adherence may reflect variations in formal influences 
(such as guidelines, training and support packages) 
across contexts and over time [24]. Some early studies 
observed that the lack of clear and consistent guidelines 
on parasite-based diagnosis may have contributed to pro-
vider tendencies to sometimes ignore RDT results [14, 
25–27]. A few recent studies have attributed high pre-
scriber compliance to quality training of clinicians and 
the provision of adequate support [11, 17]. However, 
across studies, there has been no consistent pattern indi-
cating that length of training alone is associated with pre-
scribing adherence; half-day and one-day trainings have 
preceded excellent adherence [10, 11] and a three-day 
training preceded extremely poor adherence [9]. In any 
case, the process of behaviour change from supportive 
interventions is neither linear nor rational, when external 
parameters and expectations are applied, and small dif-
ferences in context, convenience, and salience have large 
effects on the crucial choices that health workers may 
make [28].
Clinical decision-making is complex, and a variety of 
informal influences (peers, personal experiences, percep-
tions and beliefs) may also impact treatment decisions, 
potentially undermining the impact of RDT training 
and support programmes. A growing body of qualitative 
research has begun to explore provider decision-making 
in conjunction with RDT use [29–33]. Interactions with 
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peers and patients [32, 34], providers’ own learnt experi-
ence using RDTs [32], a preference for clinical diagnosis 
[33] and provider perceptions about the reliability of the 
test (combined with the recognition of malaria symp-
toms) [31] have been shown to influence anti-malarial 
prescribing decisions in various contexts. While trust of 
test results has been a recurrent theme, there has also 
been some evidence that provider capacity to confidently 
diagnose and treat non-malarial fevers may be influential 
in prescribing decision-making. A recent study from a 
microscopy setting found that patients who test negative 
do not often get an actual diagnosis and that this ‘absence 
of diagnosis’ may reinforce presumptive treatment prac-
tices [29].
Evidence suggests that context-specific behavioural 
and social factors can be influential [28] and can affect 
the practical success of a malaria diagnostic policy. To 
date, there has been little qualitative study of provider 
prescribing decision-making following a negative RDT 
result in Uganda. An early feasibility study assessing RDT 
acceptance and use found that providers were not confi-
dent about test accuracy, with just less than half believ-
ing that a negative RDT result excluded malaria [22, 27]; 
40 % of providers reported that they would not rule out 
prescribing anti-malarials to patients who tested negative 
[27]. However, this study was conducted in 2007, prior to 
the full national policy change recommending parasite-
based diagnosis for all age groups and some providers in 
the study had as little as one month experience in using 
the test.
A deeper understanding of factors driving prescribing 
behaviour in the Ugandan context is needed in order to 
develop optimal training and supporting interventions 
for successful scale-up of RDT use throughout the health 
system. This study aimed to address this gap with an in-
depth qualitative investigation of how providers manage 
patients who test negative and what informs their deci-
sion to prescribe anti-malarials during routine practice in 
a remote, rural health care setting. The results are use-
ful for guiding revisions to RDT training programmes 
and clinical and nursing school curricula, as well as for 
designing appropriate supporting interventions. The 
findings also have broader implications for clinical prac-
tice and the development of methods for diagnostic 




This study was carried out as part of a larger project 
which introduced RDTs at 88 public, lower level health 
facilities in rural mid-western Uganda in 2011. Of the five 
districts of implementation, the largest district, Kibaale, 
was selected for study. Kibaale district borders the south-
western end of Lake Albert and has an estimated popula-
tion of 613,200. The district has a referral hospital and 51 
public or private-not-for-profit health facilities, as well as 
a number of private drug shops. RDTs were introduced 
into 30 lower level public health facilities lacking func-
tional microscopy for malaria. The Ministry of Health 
selected a histidine-rich protein 2 (HRP-2) based RDT for 
deployment (SD BIOLINE malaria Ag-Pf, SD 05FK60), 
which had passed national selection criteria and was con-
firmed through WHO/Foundation for Innovative New 
Diagnostics (FIND) panel testing. Independent field eval-
uation of this RDT in a country with similar endemicity 
showed high sensitivity (92.3 %) and specificity (82.2 %) 
for Plasmodium falciparum [35], the cause of over 95 % 
of infections in Uganda [36]. Prior to RDT introduction, 
malaria was the most common outpatient diagnosis in 
the district (unpublished data), accounting for more than 
half of all outpatient visits. RDTs were introduced dur-
ing January and February 2011, starting with a training 
phase. Using a two-step cascade training model, district 
trainers were first trained in a five-day ‘training of train-
ers’ course before subsequently training 240 clinicians 
and laboratory assistants over a two-day period. Mop-up 
training was conducted in April 2011. The training fol-
lowed the recently updated, standard government RDT 
training curriculum and was led by National Malaria 
Control Programme (NMCP) personnel (two national 
trainers) with support from non-governmental organisa-
tion (Malaria Consortium) staff. Following training, all 
health facilities received an immediate follow-up visit, 
followed by supervision at six weeks and thereafter on a 
quarterly basis.
Sampling
Given the study’s focus on the drivers of behaviour for 
providers who prescribe anti-malarials to patients who 
test negative, health facilities were purposively sampled 
according to ‘prescribing performance’. Using outpatient 
registers, prescriptions were audited for a two month 
period (July–August 2011, approximately 6–7  months 
following RDT introduction), for all patients with a nega-
tive RDT result at the 30 health facilities. Health facilities 
were then ranked according to the overall proportion of 
patients with a negative RDT result who were prescribed 
an anti-malarial. Three groupings were defined according 
to imposed cut-off points within the data: (1) health facil-
ities with the lowest proportion of RDT-negative cases 
prescribed anti-malarials were categorized as ‘positive 
deviants’; (2) facilities with the highest proportion were 
categorized as ‘negative deviants’, and (3) facilities falling 
in the range between the positive and negative endpoints 
were categorized as ‘middle performers’. Positive and 
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negative deviant facilities were selected for qualitative 
investigation, with the aim of exploring the maximum 
range of provider prescribing behaviours.
All prescribing clinicians at the targeted health facilities 
were identified through interview with the health facility 
clinician in charge. Prescribing clinicians were defined as 
having consulted patients for at least ten days in the pre-
vious month. Descriptive information on provider cadre, 
age, and length of service at health facility was collected 
following the prescription audit. A total of 29 providers 
were identified and targeted for observation and inter-
view. The aim was to observe three fever cases for each 
prescribing provider. Patients were selected for observa-
tion on a rolling basis at the point of care, in accordance 
with the observation procedures described below.
Observation and provider interviews
Observations and interviews were carried out in Novem-
ber and December 2011, approximately ten months fol-
lowing RDT introduction, a cross-sectional point when 
their use was expected to have been integrated into rou-
tine practice. Observation and semi-structured interview 
guides were developed and pre-tested at health centres in 
two neighbouring districts. Four social scientist research 
assistants with a range of language skills for the con-
text were recruited and received two days training. Two 
of the four research assistants conducted observation. 
To reduce inter-observer variability, the two observers 
simultaneously observed three cases and then systemati-
cally compared transcripts for discrepancies during the 
preparatory phase.
Data collection commenced with observation. Each 
observer was assigned to one provider at the health facil-
ity per day. All attempts were made to ensure that pro-
viders continued ‘normal, everyday practice’. So as not 
to disrupt patient flow, continuous observation of the 
provider was conducted until presentation of a fever 
case. Observers did not record notes during the first 
two patient consultations (whether febrile or non-febrile 
cases), allowing time for the provider to become habitu-
ated to the observer’s presence. Thereafter, observation 
notes were taken only for febrile cases. Age strata were 
not identified in advance to avoid disrupting the natural 
process of patient care; it was expected that the resulting 
sample would contain a sufficient range of adult and child 
patients. Unaccompanied minors (less than 18  years) 
were not observed. The observation guide covered all 
aspects of a typical visit for a patient with fever, including 
taking of patient history and physical exam, introduction 
to test, test procedure, communication of and reaction 
to test, diagnosis and treatment decision and process, 
and overall patient-provider interaction. Observers were 
instructed to record everything that was said or done, 
exactly as it happened, noting the time at key intervals. 
Observers also documented if there was anything they 
were unable to observe. Diagnosis, patient complaint, 
RDT result, and prescription information were also 
abstracted from the patient’s record book prior to the 
patient’s departure from the health facility.
Provider interviews were conducted once all observa-
tions of the provider were complete. Scope of enquiry 
included demographic characteristics, training received, 
organisation of service delivery, adjustment and changes 
since arrival of RDTs, process of and opinions on 
approaches to fever case management, supervision of 
and feedback received on use of RDTs and their over-
all experiences in using RDTs. Provider interviews were 
audio-recorded and conducted in English (the training 
language of Ugandan health workers), though there was 
flexibility if providers preferred to express themselves in 
another language.
Observation notes and verbatim interview transcripts 
were prepared in the field throughout data collection. To 
avoid loss of meaning and interpretation bias, key terms 
in local languages were retained alongside the English 
translation of observed patient-provider dialogue.
Data analysis
Prescription data were compiled and cleaned in EpiData 
3.1 and analysed using Stata 12.0. Thematic analysis of 
transcribed observation and interview data followed the 
‘framework’ approach [37], whereby a pre-existing cod-
ing frame was developed based on the scope of enquiry 
to which codes were added on review of the data. All data 
were coded and indexed in Excel (Microsoft) and ana-
lysed according to the most salient themes.
Ethics, consent and permissions
The Uganda National Council for Science and Technol-
ogy granted ethical clearance for the study (UNCST 
HS 1009). For observations, informed oral consent was 
obtained from all providers. To avoid altering routine 
practice, patients and caregivers were consented for 
observation at the discretion of the clinicians, guided 
by an informed consent statement. A separate informed 
consent was subsequently obtained prior to provider 
interview. Patients and caregivers also orally consented 
for patient record review post observation. Consent 
statements included information on the broad aims of 




A total of 8344 RDT-negative patients were recorded at 
the 30 health facilities using RDTs for the two  month 
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period. 3151 (37.8  %) patients were identified at HCIIs 
and 5193 (62.2 %) at HCIIIs. Fifty-three patients had no 
treatment information in the outpatient register (either 
no prescription or prescription was not recorded). 
Table  1 describes the percentage of prescriptions con-
taining anti-malarials and antibiotics. Anti-malarials 
were prescribed in 339 episodes of the total 8344 RDT-
negative cases registered (4.1  %). Slightly less than half 
of these were prescribed artemether/lumefantrine 
(n  =  151, 1.8  % of total). Four prescriptions contained 
more than one anti-malarial. There was no difference in 
the percentage of prescriptions containing anti-malarials 
between HCIIs (n = 178, 5.7 % of HCII cases) and HCIIIs 
(n  =  159, 3.1  % of HCIII cases). Antibiotics were pre-
scribed in 6509 RDT-negative patient encounters (78 %). 
The most commonly prescribed antibiotics were trimeth-
oprim-sulfamethoxazole (cotrimoxazole) and amoxicillin. 
Of those who were prescribed an anti-malarial, 65.2  % 
(n = 221) were also prescribed at least one antibiotic.
Figure  1 shows the distribution of the percentage of 
prescriptions containing anti-malarials by health facility. 
The cut-off points for health facility selection were set at 
less than 0.75 % of patients with negative test results pre-
scribed any anti-malarial (‘positive deviants’) and greater 
than 5  % of RDT-negative patients prescribed any anti-
malarial (‘negative deviants’). Given the identification of a 
relatively large number of ‘positive deviant’ health facili-
ties for whom the percentage of RDT-negative prescrip-
tions containing anti-malarials was very low or zero, a 
sub-set was selected for qualitative investigation, accord-
ing to a range in geographical distribution (county) and 
health facility level. Of the 30 health facilities using 
RDTs, a total of 12 facilities (seven negative deviants 
and five positive deviants) were selected for qualitative 
investigation.
Study participants
Twenty-two providers were observed at 12 public health 
facilities (seven HCIIs and five HCIIIs), distributed 
across ten sub-counties. A total of 55 fever cases were 
observed (22 at HCIIs and 33 at HCIIIs); the mean num-
ber of cases observed per clinician was 2.5. Three pro-
viders were observed only once due to the conduct of 
community outreach activities and low attendance. The 
characteristics of the 22 providers observed are shown 
in Table 2. Most providers were of lower cadres (nurses 
or nursing assistants) and slightly more were female than 
male. The median age of observed providers was 37 years 
(age range of 26–59 years). All but one of the providers 
had participated in formal training on the use of RDTs 
(the remaining provider, a nursing assistant, received on 
the job training from the facility in-charge.) Most provid-
ers also reported having participated in at least one other 
training or seminar which included a patient care focus 
(mostly case management trainings for a range of infec-
tions) within the past 12 months.
All of the 55 observed patients were tested for malaria 
with an RDT. Slightly more than two-thirds (n  =  38) 
tested negative (Table  3). Negative results were not 
evenly distributed across age groups; 71 % of all observed 
RDT-negative patients were adults. The majority of 
observed patients were female (35, 63.6 %). At least one 
RDT-negative case was observed at each health facility; 
however, 40  % of the total RDT-negative case observa-
tions occurred at two HCIIIs. 53 % of all observed cases 
were managed by nurses, 40 % by nursing assistants and 
7  % by clinical officers. The average visit length (time 
Table 1 Results of the prescription audit (% RDT-negative 
prescriptions containing), spanning a two month period 
at 30 health facilities, 2011
a 2 prescriptions contained both AL and SP; 1 AL and quinine; 1 quinine and SP
N % of total
Total RDT-negative patients 8344 100.0 %
Anti-malarials 339 4.1 %
Artemether/lumefantrine (AL) 151 1.8 %
Sulfadoxine/pyrimethamine (SP) 141 1.7 %
Quinine (tabs or injection) 51 0.6 %
Total anti-malarials prescribed 341 n/a
Prescriptions containing more than 1 anti-malariala 4 n/a
Antibiotics 6509 78.0 %
Trimethoprim-sulfamethoxazole (cotrimoxazole) 4253 51.0 %
Amoxicillin 1195 14.3 %
Metronidazole 978 11.7 %
Total antibiotics prescribed 8227 n/a
Both an anti-malarial and an antibiotic 221 2.7 %
Fig. 1 Ranking and categorisation of health facility prescribing 
performance
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from beginning of consult to treatment dispensing) was 
1 h 17 min (range of 10 min to 3 h 35 min).
Observed prescription of anti‑malarials
Provider adherence to test results was high across all 
observed patients. Of the 38 observed patients with a 
negative RDT result, one was prescribed an anti-malarial 
(quinine). No observed RDT-negative patients were pre-
scribed AL. All observed RDT-positive patients were pre-
scribed anti-malarials.
Themes influencing decision‑making
Analysis of observation data and provider interview tran-
scripts identified a number of factors that appeared to 
affect provider decision-making to prescribe anti-malar-
ials to patients who tested negative. These were grouped 
into three intersecting thematic areas: clinical beliefs 
(what providers believe is the right thing to do), capacity 
constraints and the ability to make an alternative diagno-
sis (what providers have the means to do), and percep-
tion of patient demand (what providers think the patient 
wants them to do). Each of these themes is described in 
detail in the sections that follow.
Clinical beliefs: trusting results
Providers generally appreciated the importance of para-
site-based diagnosis; almost all providers acknowledged 
that it is not easy to accurately diagnose malaria based 
only on symptoms and signs. Drawing on their own expe-
rience and training, most providers reported that they 
trusted the accuracy of the test, noting, for example, that 
even patients who tested negative generally improved. 
Most providers appeared to accept that a negative RDT 
result means the patient does not have malaria and that 
fever may be symptomatic of an alternative illness or 
infection, though this was not universal. There was high 
awareness of the national parasite-based diagnostic 
policy and the requirement to restrict anti-malarials to 
patients who test positive.
“I cannot give out [AL] unless the RDTs have turned 
positive.” [HW02, Nurse-midwife, HCIII]
A few providers did however raise doubts over test 
accuracy, citing patients who tested negative by RDT and 
then later positive by blood smear examination, which 
they sometimes attributed to “other strains of malaria” 
that could not be detected by the RDT. These may have 
been examples of the ‘prozone effect’ [38], whereby the 
RDT can give a negative result due to an excess of anti-
gens or antibodies, a phenomenon which appears to be 
specific to HRP-2 tests. Two providers also mentioned 
doubts due to the time elapsed prior to reading test 
results.
“Generally I also have some doubts because one 
time my child fell sick, had all symptoms of malaria, 
when I did an RDT test, it turned out to be nega-
tive. Then the next day, I repeated the test, it again 
showed negative. Then I took the baby to hospital 
and that very night, the baby convulsed, they tested 
her… and the baby had malaria plus plus. Auto-
matically, we put the baby on quinine IV, and the 
baby improved. So because of that experience, I have 
some doubts about the RDT results because that was 
really scaring and worrying.” [HW02, Nurse-mid-
wife, HCIII]
Clinical beliefs: “you cannot get the parasites”
In line with observed practice, providers by and 
large reported that they prescribed anti-malarials to 





 Female 6 8 14 (64 %)
 Male 4 4 8 (36 %)
Cadre
 Nursing assistant 5 4 9 (41 %)
 Nurse 4 7 11 (50 %)
 Clinical officer 1 1 2 (9 %)
Year of last qualification
 1991 and before (more than 20 years prior) 3 0 3 (14 %)
 1992–2001 (10–19 years prior) 0 3 3 (14 %)
 2002–2011 (within last 10 years) 7 9 16 (73 %)
Number of years at health facility
 Less than 1 year 2 1 3 (14 %)
 1–5 years 5 8 13 (59 %)
 6 or more years 3 3 6 (27 %)
Age
 30 and younger 4 5 9 (41 %)
 31–45 1 7 8 (36 %)
 46 and older 4 0 4 (18 %)
Total 10 12 22
Table 3 RDT results of observed patients by age group
RDT‑negative RDT‑positive Total
N (%) N (%) N (%)
Adult 27 6 33 (60.0 %)
Child 11 11 22 (40.0 %)
Total 38 (69.1 %) 17 (30.9 %) 55 (100.0 %)
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RDT-negative patients in rare circumstances, if at all. 
When they did so, it was driven by a clinical rationale. 
For example, in cases where patients had already taken 
ACT prior to coming to the health facility, some provid-
ers seemed to presume treatment failure due to resist-
ance, even when there was no prior confirmation that the 
patient had malaria. In such cases, providers reported 
shifting ‘automatically’ to prescribing a second-line anti-
malarial (which at the time of study in Uganda had offi-
cially changed to dihydroartemisinin piperaquine for 
uncomplicated malaria, with quinine tablets remaining 
the alternative and more readily available second-line 
treatment). The one observed patient who was prescribed 
an anti-malarial despite a negative test result, was pre-
scribed quinine, after having reported taking a partial 
dose of AL prior to coming to the health facility (Fig. 2).
Providers appeared to reconcile the need for anti-
malarial treatment with the negative RDT result, noting 
that in these cases (after taking ACT) “you cannot get the 
parasites”. The specificity of provider rationales seemed 
to suggest a limited understanding of how the antigen-
based test works (what exactly the test identifies), rather 
than more pervasive doubts about test accuracy. In cases 
where providers reported presumptively treating malaria, 
providers did not mention the diagnostic possibility of a 
non-malaria febrile illness. However, there was no evi-
dence to suggest that the prescription of anti-malarials 
precluded the prescription of other treatments.
“There are some times when I give quinine injection 
when the patient has signs like shivering, vomiting, 
headache, very high temperature, etc. yet the patient 
had taken [AL], but is still very sick. At that point 
I can give quinine injection even if the RDT was 
negative because in most cases if the patient takes 
any anti-malaria drugs before testing, there is a 
possibility of the results turning out negative. How-
ever, that does not mean that the patient doesn’t 
have malaria. So, in such instances, I give second 
line treatment which is quinine… In most cases it’s 
the patient history and examination that gives an 
option to give anti-malarial drugs or not.” [HW20, 
Nurse in charge, HCII]
Capacity: “treat what you know”
Providers generally felt that the use of RDTs was a posi-
tive, enabling change that enhanced their capacity to pro-
vide quality care; specifically, they no longer had to rely 
on “guesswork” and could now “treat what you know”.
“At least one treats what one is knowledgeable about 
and not depending on guesswork.” [HW12, Nursing 
Assistant, HCIII]
A couple of providers explicitly acknowledged 
improvements in patient outcomes, noting that when 
they treated presumptively, patients failed to improve 
because they were not treating the right illness. One tied 
this to making it easier to identify treatment failures and 
knowing when to prescribe a second-line treatment. A 
number also mentioned that RDT use helped to reduce 
drug resistance and ACT wastage. Some providers also 
reported a sense of pride from practicing new skills and 
increased confidence in managing patients.
“The main importance is to really know what we 
are treating… for all the years we have been treat-
ing people, many complain of fevers and yet they are 
A 60-year old female patient [PT07] presented to a HCIII complaining of headache, cough and fever. The 
provider [HW03, Nursing assistant] asked the patient what she had already done to treat the illness. The 
patient reported that she had taken an ACT. 
HW: “How many tablets did you take and where did you get them?”  
The provider also examined the palms of the patient’s hands, took her temperature and asked the patient 
whether she felt any dizziness. He then explained that he was going to test her blood and carried out an RDT, 
which yielded a negative result.  
HW: “Your results are negative, so you do not have malaria. Remember madam, you mentioned that you took 
some antimalarials, which means ever since you took that medicine, it could be having an impact as to why the 
results are negative. Did you become better after taking the medicine?”  
PT: “I was actually taking 4 [AL] tablets every day only and there is no change – that is why I have come here at 
the health facility.” HW (looking surprised): “You said you were only taking four tablets of [AL] per day. That is 
not the right prescription. You self-medicated yourself, which means you did not finish the whole dose. It 
seems that is where the problem of fever resistance is coming from.”  
After consulting with another health worker, the provider then prescribed quinine tablets, along with 
amoxicillin, paracetamol and multivitamins. 
During interview, the provider explained his treatment rationale: “When a patient has been using anti-malaria 
under-dose in the village and you clinically see that the patient is having malaria, but when tested they may be 
negative, I give a stronger anti-malaria drug.”  
Fig. 2 Observation notes: RDT-negative patient prescribed an anti-malarial
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suffering from other illnesses. Secondly, RDT testing 
has helped us a lot in controlling the community. 
Those days they would ask for antimalarial drugs 
by saying ‘“Musawo” [health worker, in Runyoro-
Rutooro], give me some drugs for my children at 
home, they are suffering from fever’ but [now], be it 
here or any bigger health facility, they first have to 
carry out test before giving you treatment”. [HW09, 
Nursing Assistant, HCII]
Capacity: limited patient assessment and diagnostic 
practices
While providers appeared to value RDTs as a confirma-
tory diagnostic, in observed practice they demonstrated 
limited capacity to diagnose non-malarial fevers. Pro-
viders collected minimal information from the patient, 
rarely taking a patient history (beyond key complaint 
or symptoms and their duration), conducting physical 
examinations, or enquiring about the presence of spe-
cific symptoms which could be associated with common 
causes of fever. In a number of cases there was simply no 
consultation beyond the initial registration of the patient 
(name, age, village and patient complaint were requested 
and recorded in the patient’s record book). Following 
a negative RDT result, providers were observed to take 
some additional diagnostic action in about a quarter of 
cases (distributed across providers). These actions were: 
asking additional questions, generally reflecting a lack of 
initial history taking (e.g. “Does he have cough?”); offering 
advice or suggesting the need for additional testing, but 
without referral (e.g. “If you think you have typhoid you 
have to go and seek treatment from elsewhere”); and refer-
ring to a higher level health facility for additional testing 
and care (one child presenting with danger signs, two 
adults for typhoid testing).
Providers did not formulate clear diagnostic state-
ments, with recorded information being generally lim-
ited to patient complaints, RDT result and prescribed 
drugs. Providers were observed to be performing largely 
as drug dispensers. The common response to a negative 
RDT result was to simply prescribe for other symptoms 
present (e.g. cough), with the prescriber typically treat-
ing the test result and each patient complaint indepen-
dently. Although patients were not systemically sampled 
for observation (and RDT-negative and RDT-positive 
patients were not comparable with regards to age distri-
bution), on average, slightly fewer drugs were prescribed 
for the observed RDT-negative patients: 2.94 drugs per 
prescription versus 3.41 for RDT-positive patients. Over-
all, antibiotic prescription was high across both positive 
and negative patients: 45 of the 55 observed patients 
were prescribed at least one broad-spectrum antibiotic. 
Just one of the 38 patients who tested negative was pre-
scribed only an antipyretic.
Capacity: constraints
Providers’ limited ability to make an alternative diag-
nosis for patients with negative RDT results appeared 
to be associated with three main constraints: a lack of 
know-how and low level of clinical skills, a lack of other 
point-of-care diagnostics and insufficient time due to 
understaffing and high workloads.
Providers generally knew what they should do follow-
ing a negative result; most reported that they review the 
patient history or investigate other causes of fever. Most 
also mentioned referral or requesting the patient return if 
no improvement as possible courses of action. However, 
knowledge of what to do following a negative result com-
monly appeared more theoretical than practical (provid-
ers had ‘knowledge that’ they should investigate further, 
but had less ‘knowledge how’ to go about doing so). Some 
vaguely mentioned that they try to “find out other causes of 
fever”, without describing with any specificity how they go 
about doing so. A few providers only mentioned that they 
“treat other complaints” and a small group (primarily nurs-
ing assistants) focused on patient communication, noting 
that they reassure the patient or explain that other things 
can cause fever. Underscoring the observed lack of diagnos-
tic statements, many providers expressed simplistic ideas 
about febrile illness. Most providers tended to conflate 
symptoms and disease aetiology; cough and headache were 
frequently referred to as “causes of fever”. A few providers 
did not accurately express illness concepts, misusing terms 
such as fever, malaria and high body temperature. This 
practice was likely an artefact of illnesses classifications in 
local languages—although malaria is more precisely trans-
lated into Runyoro-Rutooro (a dominant language of the 
region) as “omuswijja gw’emibu”, a single word, “omuswi-
jja”, is frequently used to mean both fever and malaria—but 
also seemed indicative of possible clinical confusion, par-
ticularly amongst older nursing assistants (40, 52 years).
“[A negative result] means that the patient does not 
have any fever, but could be having other infections 
like wounds or cough… When the results are posi-
tive, I tell the patient, I have tested you and found 
out that you have got fever (“omuswijja”)… In case 
a patient is having negative RDT results, I tell them 
that ‘we have tested your blood and you do not have 
fever (“omuswijja”), so which means it is either the 
cough or headache causing the fever depending on 
the patient’s other complaints. If it is cough, I then 
give them medication for cough and assure them 
that they will be fine”. [HW15, Nurse in charge, HCII, 
52 years]
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Providers also reported limited to no use of clinical 
guidelines to aid in diagnostic decision-making, an attes-
tation which was validated in observed practice. In train-
ing, providers were advised to refer to the ‘Integrated 
Management of Childhood Illness’, ‘Uganda Clinical 
Guidelines’ and a list of treatment protocols for com-
mon causes of fever provided in the national ‘RDT User’s 
Manual’. Although most providers reported that they had 
at least one of these guidelines readily available, most also 
forthrightly explained that they did not refer to them in 
practice. One explained (quite accurately) that he did not 
have any specific guidelines to aid in diagnosing non-
malarial fevers or managing patients who tested nega-
tive. The lack of other diagnostic tools or ability to test 
for other diseases (typhoid in particular) was also cited as 
a constraint by providers.
Most providers complained about the high workload 
associated with using RDTs. Providers reported that they 
were now doing additional tasks and that it required “too 
much time per patient to manage properly”, particularly in 
a context where they were often working alone to manage 
an “overwhelming number of patients”. However, some 
providers noted how this additional time spent with the 
patient was beneficial: “If somebody comes with different 
complaints, at least now I interact with them at length, I 
talk with patients”. [HW02, Nurse-Midwife, HCIII].
In spite of these reported challenges, a belief in doing 
the right thing for the patient (responsibility to treat) 
and a desire to ration ACT use appeared to override the 
workload constraint.
“Much as the work is too much for me, I think it’s 
better than treating what I don’t know.” [HW05, 
Nursing Assistant, HCIII]
Capacity: “nothing else we can do”
In the absence of an alternative diagnosis, a small num-
ber of providers reported that they sometimes pre-
scribed anti-malarials in part because they perceived no 
other options to be available. Although most providers 
explained that they referred the patient or first consulted 
with others at the health facility when they were unable 
to determine cause of fever, two mentioned sometimes 
treating RDT-negative patients with an anti-malarial 
when they were unable to make an alternative diagnosis. 
These providers’ perceived lack of options appeared to 
result from a lack of confidence in an alternative diagno-
sis/treatment and an underlying fear of missing the true 
diagnosis or risking death, particularly when faced with 
a very ill patient. This did not appear to be linked to the 
availability of other treatments. In addition, some provid-
ers also suggested that “other health workers” (particularly 
those with lower qualifications) prescribed anti-malarials 
to patients who test negative because they lack the confi-
dence or skills to manage the patient properly.
“At times we treat because you see all the signs of 
malaria are there, so in such cases we treat because 
there is nothing else we can do… Also when you 
have volunteers and they lack experience and when 
patients come they just give out the [AL] because 
they cannot further to establish the possible cause of 
fever”. [HW11, Nurse, HCIII]
“There are times when I am forced to give them anti-
malarials, especially when the sickness is too much 
and they become better later… even when the RDT 
results are negative… But if the situation persists, I 
then refer.” [HW18, Nursing Assistant, HCII]
“…my colleagues give it [AL] out due to lack of confi-
dence and when the patient is looking so sickly they 
just treat. In the recent past we have met and agreed 
that if you are not confident, refer to microscopy or 
just be confident that the drug you have prescribed 
will heal the patient… I cannot deny the truth, my 
colleagues here do it and the reasons could be lack 
of confidence and they think they have missed proper 
diagnosis”. [HW01, Nurse in charge, HCIII]
Perceptions of patient demand
Providers commonly viewed “patient refusal” as a major 
challenge and often perceived refusal as relating to the 
test and a desire for AL. Most providers reported that 
they had been pressured to prescribe anti-malarials to 
RDT-negative patients at some time and that patient 
reactions to RDTs affected their work (e.g. more time to 
counsel and explain results to patients).
“The most challenging part is communicating the 
results to the patient because some patients come 
here with a belief that they have malaria and expect 
to get treatment, so telling them a negative result is 
a disappointment on their side”. [HW20, Nurse in 
charge, HCII]
Although providers almost universally complained that 
patient reactions were a challenge, most were adamant 
that they did not allow this to influence their prescribing 
practices. Nonetheless, perceived patient acceptance was 
indirectly cited by a few providers as a reason for giving 
anti-malarials to patients who tested negative: Two pro-
viders (both nursing assistants) reported sometimes giv-
ing SP to placate RDT-negative patients or because they 
believed a patient should not go away empty-handed. 
This acquiescence to perceived patient demand appeared 
to be conflated with a ‘desire to treat’ and help the patient 
(providers wanted to provide treatment, but may have 
lacked the capacity to identify the right treatment for the 
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patient). Others mentioned “patient pressure” as a factor 
influencing their colleagues’ behaviour.
“The most challenging thing is patients rejecting 
results and it’s in those kinds of instances that I 
decide to give [SP]”. [HW19, Nursing Assistant, Act-
ing in charge, HCII]
“There was one time when a man came and he 
wanted to be given [AL]. When he arrived he never 
even went for diagnosis but moved direct to the dis-
pensing window and started demanding for [AL]. 
We all refused and convinced to have him tested 
first and, upon testing, he was negative. After refus-
ing to give him the [AL] he came back the following 
day complaining and we had just to give him and he 
did not come back again”. [HW10, Nurse in charge, 
HCIII]
Discussion
While there was some range in prescribing performance 
observed across health facilities, the study found much 
higher overall adherence to test results than observed 
in earlier studies in Uganda [22, 23]. This could in large 
part be due to changes in national policy recommenda-
tions – earlier studies were conducted prior to the full 
national policy change recommending parasite-based 
diagnosis for all age groups—and in the composition of 
training and support packages. In this setting of routine 
use, providers underwent specific training on the clinical 
management of patients who test negative and received 
regular supervision, with clear guidance that they should 
not prescribe anti-malarials to patients who tested neg-
ative; this likely curtailed misuse. The timing of data 
collection (conducted once the programme was estab-
lished, rather than immediately following or coinciding 
with RDT introduction) may also have affected find-
ings. Earlier studies assessed provider views and experi-
ences shortly after implementation, which may not have 
allowed sufficient time for providers to form opinions on 
the role of RDTs in diagnostic and treatment decision-
making [27]. While it has been suggested that provider 
adherence improves over time [20–22], it has also been 
observed that initial improvements may not be sustained 
over the longer-term [13]. However, it would seem likely 
that these effects are mitigated by the ongoing presence 
or absence of supporting interventions. A desire to ration 
ACT in a context of recurrent stockouts, combined with 
high awareness of the national treatment guidelines 
restricting ACT prescription to patients who test posi-
tive, may also have limited prescription of anti-malarials 
to patients who tested negative. However, it is also possi-
ble that providers under-recorded anti-malarial prescrip-
tion to patients who tested negative, knowing that this 
deviated from guidelines and that outpatient records may 
be reviewed by supervisors.
While adherence to test results was high, this study 
found some key interplaying factors influencing provid-
ers to prescribe anti-malarials to patients who tested 
negative. Some anti-malarial prescription was driven by 
perceptions of treatment failure or undetectable malaria 
in patients who had already taken ACT prior to coming 
to the health facility. Capacity constraints, including a 
lack of provider know-how, time, and alternative diag-
nostics, appeared to considerably affect provider ability 
to make an alternative diagnosis. Limited routine diag-
nostic practices (i.e. history taking, physical examination) 
meant that providers collected little information that 
would aid them in treatment decision-making. Percep-
tions of patient demand for treatment, coupled with per-
ceived patient rejection of test results, also appeared to 
result in some anti-malarial (SP) prescription to patients 
who tested negative.
The particular issues which arose relating to testing and 
treating following ACT use require further consideration. 
Some providers reported ‘automatically’ shifting to a sec-
ond-line treatment (quinine) despite a negative test result 
(apparently attributing suspected treatment failure to 
drug resistance). In these circumstances, it appeared that 
anti-malarial prescription decision-making was driven by 
a combination of intuitive and rationalistic approaches. 
On the one hand, after years of presumptive treatment, it 
seems likely that providers remain predisposed to seeing 
malaria as the most likely explanation for persistent fever. 
Findings suggest that underlying fears of missing a diag-
nosis and concerns for patient safety remain influential, 
particularly in a remote context where the consequences 
of delayed treatment can be fatal. Presented with a 
patient with persistent fever who is manifestly ill and has 
already taken ACT, providers may also tend toward pre-
sumptive treatment “just in case it may help the patient”, 
as one provider put it.
At the same time, some providers applied a rationalis-
tic approach, describing an analytic framework in which 
“you cannot get the parasites” after ACT administration. 
However, it was less clear what the underlying logic was 
for this belief. In contrast to earlier research in Uganda 
[22] and elsewhere [31], providers in this study did not 
appear to be strongly influenced by underlying doubts 
about the accuracy of test results. It is possible that some 
providers may have thought that patients who already 
took ACT had undetectable malaria due to low parasi-
taemia (since the administered ACT would have reduced 
the parasite load), however this was not articulated. It 
was also not clear how providers may have reconciled 
the suspected presence of low levels of undetectable 
parasites with the clinical presentation of a manifestly ill 
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patient, which was frequently mentioned as the initial, 
driving rationale for suspecting malaria and prescribing 
anti-malarial treatment. Alternatively, it is possible that 
providers did not have a clear understanding of what the 
test detects. There may have been issues related to the 
deployment of HRP-2-based tests that influenced provid-
ers’ understanding of how the RDT works and the ability 
of the RDT to detect malaria following ACT use. Inci-
dentally, there also appeared to be at least one example 
of a false negative RDT result due to the ‘prozone’ effect 
[38], concerning from the perspective of incorrect diag-
noses as well as for the potential for raising distrust in the 
test itself.
The challenges related to an inability to diagnose and 
treat non-malarial fevers have been well-documented 
[27]. It was found that providers’ treatment decision-
making for patients who tested negative was in part 
influenced by various capacity constraints, starting with 
providers’ limited clinical know-how and diagnostic 
skills. On occasion, some providers reported prescribing 
ACT as a result of capacity constraints (simply because 
they lacked other options). The confluence of multiple 
pressures—the responsibility to save lives, a high work-
load and low level clinical skills—appeared to foster a 
general ‘expediency’ approach in which providers may 
choose a ‘path of least resistance’. Time pressures may 
force providers to expedite the care process, limiting 
their interaction with the patient and inhibiting their 
ability to probe just when they need to ‘dig deeper’ for 
other causes of fever. An absence of diagnosis and clear 
alternative treatment plan, in turn, may render provid-
ers more susceptible to perceived patient pressure. These 
combined circumstances may influence a provider to 
decide that it is easier ‘to just give’ an anti-malarial.
As providers lacked specific guidelines or algorithms to 
aid in the diagnosis and treatment of patients who tested 
negative, it is also unsurprising that providers appeared 
to rely largely on intuitive decision-making. Given that 
point-of-care diagnostics for other common causes of 
fever to be deployed at low level health facilities are not 
yet forthcoming [39], there is an urgent need to develop 
better methods for assisting providers in diagnostic 
decision-making. However, despite these constraints, 
providers did not seem to make the most of the limited 
means they had available. Whether due to limited time, 
excessive workload, lack of confidence or ability, provid-
ers rarely appeared to make the most of their interaction 
with the patient to collect information that would aid 
them in making a differential diagnosis.
Other studies have observed a potential trade-off 
between the overprescription of anti-malarials and the 
overprescription of antibiotics in settings of RDT use [19, 
40–42]. In this study, the potential overuse of antibiotics 
appeared to be more an indication of symptom-based, 
multiple prescribing practices (polypharmacy) than a 
trade-off associated with RDT use, although this prac-
tice may be exacerbated when the diagnosis is uncertain. 
Moreover, the very small number of patients observed to 
receive no treatment or only supportive treatment (anti-
pyretic) suggests that providers either rarely considered 
self-limiting, viral infections or that they were being 
responsive to perceived patient expectations for drugs.
Pressure to conform to perceived patient preferences 
has been found to be influential in some settings [43], 
although some evidence has suggested that this is not a 
primary driver of prescription practices [44]. Providers in 
this study reported that patient demand for anti-malar-
ials did not affect their prescription practices following 
testing, though a desire to treat the patient and a lack of 
other options sometimes influenced them to prescribe SP 
as a ‘consolation’ treatment. Replacement of ACT with 
SP prescription in the management of RDT-negative 
patients has been observed elsewhere [45] and the study’s 
findings are in line with earlier results from Uganda, 
which observed that some RDT-negative patients were 
given non-ACT malaria treatments, as providers felt 
they could thus ‘save ACT’ for those who tested positive 
and still meet patient expectations [27]. In this study, the 
decision to prescribe SP to patients who tested negative 
was predominantly linked to a desire to provide some 
treatment to the patient (so that he would not go “empty-
handed”), rather than a strong belief in its efficacy or 
appropriateness as treatment. Providers were also very 
much aware of guidelines, and perhaps perceived this as a 
way of circumventing the policy regarding ACT use.
Table  4 summarizes the main, intersecting themes 
influencing providers to prescribe anti-malarials to 
patients who tested negative in this context, positive 
influencers in promoting adherence to RDT results, and 
potential implications for provider behaviour change, 
specifically the design of training and appropriate sup-
porting interventions. Behaviour change is affected by 
a complex set of factors and it will be important for all 
interventions to be appropriately designed in consulta-
tion with targeted stakeholders to ensure relevance to 
their social realities.
Limitations
This study had some potential limitations. It is possible 
that providers may have under-recorded anti-malarial 
prescription to patients who tested negative, but there 
was no alternative data source available for validation. 
Similarly, providers may have under-reported what they 
knew to be unacceptable behaviours (including prescrib-
ing anti-malarials to patients who tested negative) dur-
ing interview. Probing techniques and multiple lines of 
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questioning were used to elicit providers’ true beliefs 
and behaviours and encourage providers to feel that all 
responses were acceptable. It is also possible that pro-
viders may have altered their behaviour (attempted to 
perform better) during observation because they were 
aware they were being watched (observer-expectancy 
effect). Data collection procedures, observer techniques 
(habituation) and training aimed to limit this effect and 
capture providers as they usually perform. The use of 
multiple methods of data collection and triangulation of 
data also helped to minimize any researcher bias in the 
overall analysis. This study largely observed providers 
of lower cadres (nurses and nursing assistants), which 
limited the possibility of observing potential differences 
in behaviour by provider cadre. The sample of observed 
cases was also relatively small, with only one RDT-neg-
ative case being prescribed an anti-malarial. Finally, 
it happened that there was an uneven distribution of 
positive and negative test results across child and adult 
patients, limiting opportunity to compare care prac-
tices between RDT-positive and RDT-negative patients 
and to interpret any potential differences between adult 
and child patients in terms of diagnostic or prescribing 
behaviour.
Conclusions
This study found overall high provider adherence to test 
results, but that providers believed in certain clinical 
exceptions and felt they lacked alternative options fol-
lowing a negative result. Although providers generally 
trusted the accuracy of RDTs, anti-malarial prescrip-
tion was driven by perceptions of treatment failure or 
undetectable malaria in patients who had already taken 
ACT prior to coming to the health facility. Capacity con-
straints, specifically a lack of alternative diagnostic tools, 
provider know-how and time, and limited routine diag-
nostic practices all hampered the ability of providers to 
identify alternative diagnoses. Perceptions of patient 
demand for treatment, coupled with perceived patient 
rejection of test results, also appeared to drive some anti-
malarial prescription following negative test results. The 
observation that providers may replace ACT prescrip-
tion with an alternative anti-malarial is important and 
warrants focus. Guidance on how the antigen-based 
tests work and testing following partial treatment doses, 
as well as better methods for assisting providers in diag-
nostic decision-making, are needed. Guidance provided 
should be as practical as possible to avoid leaving ‘grey 
zones’ which could lead to misinterpretations in clini-
cal decision-making. Further exploration is also needed 
on how best to equip providers to make the most of their 
interaction with the patient. This has implications for 
organisation of care and should include exploration of 
how to most effectively balance the drive for efficiency 
with quality patient communication. A number of oppor-
tunities for influencing provider behaviour change to fur-
ther adhere to negative RDT results have been suggested. 
Behaviour change is complex and requires a multitude 
of complimentary interventions relevant to the social 
realities of the providers, which could include review and 
clarification of guidelines, training, supervision, perfor-
mance improvement and capacity building.
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